Home
 /
Papers
 /
Biochemistry
 /
Nitrogen deletion in HDAC-targeting anticancer drug biosynthesis
Preprint
Open access
Top 1% · Validated by QED

Nitrogen deletion in HDAC-targeting anticancer drug biosynthesis

Xinyun Jian, Jinlian Zhao, Edward Marschall +8 more
October 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.03.13.642940
99
%
QED Score
QED Impressions

Revealing the first nitrogen-deletion mechanism in natural product biosynthesis, this work overturns the assumption that enzymatic heteroatom editing excludes nitrogen and unlocks chemoenzymatic routes to next-generation HDAC inhibitors targeting a clinically validated pharmacophore.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Nitrogen deletion from a cysteine-derived intermediate during depsipeptide HDAC inhibitor biosynthesis proceeds through a novel multistep mechanism involving multifunctional PKS domains and trans-acting phosphotransferase and flavin-dependent oxidoreductase enzymes, with this deletion being critical for potent HDAC inhibition as hydroxylated analogues show thousand-fold reduced activity, and the complete pathway can be reconstituted in vitro to enable biocatalytic synthesis of the conserved pharmacophore.

See full analysis
Main Claim 1 –

PcdF, PcdG and PcdI are essential for pharmacophore biosynthesis

Supporting evidence

  • NRPS-PKS domains previously annotated inactive retain conserved catalytic residues
  • Conserved tailoring enzyme roles are shared across depsipeptide HDAC producers
Main Claim 2 –

Nitrogen deletion enables potent HDAC inhibition; hydroxylation reduces activity

Main Claim 3 –

Atypical heterocyclisation domain catalyzes cysteine S-octanoylation in initiation

Supporting evidence

  • Romidepsin proteins substituted for insoluble FR901375 enzymes in reconstitution
Main Claim 4 –

Nitrogen deletion via DepG phosphorylation and DepF flavin-dependent elimination

Supporting evidence

  • Nitrogen deletion involves imine hydrolysis confirmed by 18O labeling
  • Synthetic substrates and cysteamine offloading validate DepB/DepG/DepF functions

Abstract

Small molecules play indispensable roles in living systems as hormones, membrane bilayer constituents, enzyme cofactors, metal chelators, and defensive chemicals. The exceptional structural diversity of such molecules underpins their wide-ranging biological functions. Precise functional group insertion into various molecular scaffold classes is a hallmark of small molecule biosynthesis and is frequently important for biological activity. Functional group deletion is also important, but mechanisms are less well understood. Here, we report deletion of a cysteine-derived nitrogen atom during assembly of the conserved pharmacophore in the anticancer drug romidepsin, and related depsipeptide HDAC inhibitors. A shunt metabolite hydroxylated at the cysteine-α-carbon-derived position is a thousand-fold less active, indicating nitrogen deletion is important for potent HDAC inhibition. In vitro reconstitution and dissection of the complete nonribosomal peptide synthetase-polyketide synthase-mediated pathway for pharmacophore assembly reveal that cryptic S-octanoylation is catalysed by an atypical heterocyclisation domain, while multifunctional dehydratase and ketoreductase domains and trans-acting phosphotransferase and flavin-dependent oxidoreductase enzymes catalyse successive transformations in nitrogen deletion. Our findings significantly advance the understanding of heteroatom deletion mechanisms in small molecule biosynthesis and highlight the key role this can play in enhancing bioactivity. One-pot biocatalytic synthesis of the pharmacophore provides foundations for chemoenzymatic approaches to next-generation HDAC inhibitors.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?